首页 / 院系成果 / 成果详情页

RECORD-4: A multicenter, phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC) 会议论文

编号：

81873399-bc70-465f-b0cd-1926c3e42a57
作者：

Motzer, Robert; Alyasova, Anna; Ye, Dingwei; Karpenko, Andrey; Li, Hanzhong; Alekseev, Boris Y.; Xie, Liping; Kurteva, Galina Petrova; Kowalyszyn, Ruben Dario; Neron, Yeni; Cosgriff, Thomas; Collins, LaTonya; Brechenmacher, Thomas; Segal, Scott; Morgan, Liza M.; Yang, Lin
作者单位：

Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Prevoljskiy Reg Med Ctr, Novgorod, Russia; Fudan Univ, Canc Hosp, Shanghai 200433, Peoples R China; Leningrad Reg Oncol Dispensary, St Petersburg, Russia; Beijing Union Med Coll Hosp, Beijing, Peoples R China; Hertzen Canc Res Inst, Moscow, Russia; Zhejiang Univ, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; Specialized Hosp Act Treatment Oncol, Sofia, Bulgaria; Ctr Invest Clin Clin Viedma SA, Viedma, Argentina; Ctr Pesquisas Oncol CEPON, Florianopolis, SC, Brazil; East Jefferson Gen Hosp, Crescent City Res Consortium, Metairie, LA USA; Novartis Pharmaceut, E Hanover, NJ USA; Novartis Pharma SAS, Rueil Malmaison, France; Novartis Pharmaceut, E Hanover, NJ USA; Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China
会议名称：

JOURNAL OF CLINICAL ONCOLOGY
会议时间：
出版信息：

2015 年 33 卷 15 期

浏览次数：1  下载次数：0

浏览次数：1

下载次数：0

打印次数：0